Clinical Scorecard: Definitions and Diagnostic Criteria for Residual Stone Fragments: A Systematic Review

At a Glance

Key Highlights

• RSFs are a significant clinical challenge post-lithotripsy and endourological procedures, impacting patient outcomes and healthcare burden.
• Non-contrast CT is the gold standard imaging modality for detecting RSFs due to superior sensitivity, despite cost and radiation concerns.
• Lack of standardized definitions and criteria for clinically significant RSFs complicates management and follow-up protocols.

Guideline-Based Recommendations

Diagnosis

• Use non-contrast computed tomography (NCCT) as the preferred imaging modality for detecting RSFs.
• Consider ultrasonography and radiographs as adjuncts with awareness of their limitations.
• Standardize RSF size criteria, with many studies defining clinically insignificant RSFs as fragments smaller than 4 mm.

Management

• Aim for stone-free status defined as absence of detectable fragments on imaging.
• Stratify patients based on RSF size, number, location, and clinical presentation to guide management decisions.
• Employ enhanced irrigation and laser technologies during endourological procedures to minimize RSFs, though long-term benefits require further validation.

Monitoring & Follow-up

• Implement follow-up imaging protocols tailored to RSF risk stratification to monitor fragment progression or complications.
• Use consistent imaging modalities and timing post-procedure to assess residual fragments accurately.

Risks

• Recognize RSFs as risk factors for stone regrowth, urinary tract infection, obstruction, and need for additional interventions.
• Consider radiation exposure risks when selecting imaging modalities, balancing diagnostic accuracy and patient safety.

Patient & Prescribing Data

Adults treated for kidney stones with ESWL, PCNL, or RIRS

Residual fragments smaller than 4 mm are often considered clinically insignificant, but size, composition, and patient symptoms should guide further treatment and monitoring.

Clinical Best Practices

• Adopt standardized definitions and classification systems for RSFs to improve consistency in clinical practice and research.
• Use NCCT imaging preferentially for accurate detection and assessment of RSFs.
• Develop and apply risk stratification models incorporating RSF size, number, and clinical factors to personalize patient management.
• Ensure multidisciplinary review and consensus in ambiguous cases to optimize patient outcomes.
• Balance imaging modality choice with considerations of cost, availability, and radiation exposure.

References

• European Association of Urology Guidelines on Urolithiasis
• Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)
• QUADAS-2 Tool for Quality Assessment of Diagnostic Accuracy Studies